Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the introduction of the industry's first full-service, at-home, 12-lead electrocardiogram (ECG) solution for use in decentralized clinical trials. The clinical-grade solution is the most advanced patient-centric ECG offering within the company's cardiac monitoring portfolio, pairing data readings comparable to clinical, site-based ECGs with Philips leading cloud-based data collection and analysis services.
Huma has bought iPLATO Healthcare, whose patient engagement software covers a network of 26.6m patients across nearly 3,000 NHS primary care organisations and whose myGP app is one of the most downloaded medical apps in the UK. The two companies will continue to operate independently but will combine their expertise to enable more proactive, predictive and personalised care for patients in a joined-up service across primary and secondary care.
Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, announced physicians will now have access to advanced new 3D image guidance capabilities through its Image-Guided Therapy Mobile C-arm System - Zenition, delivering enhanced clinical accuracy and efficiency, and aiming to improve the outcomes for patients undergoing endovascular treatment.
CliniSys is announcing the recent acquisition of HORIZON Lab Systems and the combination with Sunquest Information Systems, as CliniSys. This acquisition and Sunquest combination creates one of the world’s largest organisations dedicated to diagnostic and laboratory informatics.
Mjog by Livi has launched a remote monitoring tool that will help GPs support and monitor people with depression through messages sent to their smartphones.
The latest data from the Office of National Statistics (ONS) found that 1 in 5 British adults experienced some form of depression in the first quarter of 2021, compared to 1 in ten before the pandemic.